Monday, June 15, 2026

Clash in the Assembly: South Korea’s Political Crisis Deepens

On the 26th, the Presidential Office criticized...

Samsung’s Galaxy S25 Gets Rave Reviews at Launch Event, Promising a Convenient Future

The Galaxy S25's AI features impressed first customer Seo Kyung Deok at SK Telecom's launch event in Seoul, enhancing user experience.

How the New U.S. Investment Special Law Could Shield South Korea from Tariff Threats

Kim Sang-hoon predicts the U.S. Investment Special Act will stabilize tariffs, enhancing investment and cooperation between Korea and the U.S.

Tag: rare

North KoreaKoreaKimMilitaryAISouth KoreamarketrelationsInternational

Gene Editing Study Suggests New Treatment Path for Rare Krabbe Disease

A study reveals adenine base editing may treat Krabbe disease, offering hope for rare genetic disorders through precise gene correction.

Samsung’s G-CROWN Platform is Revolutionizing Gene Therapy for Rare Diseases in Asia

Samsung Medical Center launches G-CROWN platform to develop gene therapies for rare diseases, aiming to reduce reliance on imports.

YH35995: A Game-Changer for Gaucher Disease? FDA Grants Orphan Drug Designation

Yuhan Corp's YH35995 for Gaucher disease receives orphan drug designation, enhancing its development for rare diseases with unmet needs.

Unlocking Genetic Insights: Family Insight Test Launches for High-Risk Families in Asia

3billion launches the Family Insight Test, a genomic diagnostic tool for high-risk families, enhancing genetic risk assessment and family planning.

1 Trillion KRW Donation: How the Lee Kun-hee Legacy is Transforming Infectious Disease Research in Korea

Samsung's donation aids childhood cancer and rare diseases, funding research and infrastructure to combat infectious diseases in South Korea.

3Billion Partners with Austin: What This Means for Rare Disease Diagnostics in the U.S.

3Billion partners with Austin for a new lab to enhance rare disease diagnostics and expand its U.S. market presence.

Unlocking Rare Diseases: How AI and Whole Genome Sequencing Achieved 46.2% Diagnostic Success in Korea

Three Billion, an AI-based rare disease diagnostic company, collaborates with Seoul National University Hospital on a major genomic study.

Top News

- Our Sponsors Ad -

Follow us

Cars

Tech

future

health

© Copyright by News1. All Rights Reserved.